Candel Therapeutics Inc — Bilancio Trimestrale (NASDAQ:CADL) | MetaTrader

Apri il grafico completo

Notizie

H.C. Wainwright conferma il rating su Candel sui dati sul cancro ai polmoni

Candel reports extended survival data for lung cancer therapy

H.C. Wainwright conferma il rating buy su Candel Therapeutics

H.C. Wainwright reiterates Candel Therapeutics stock rating at buy

Candel annuncia presentazione orale sui dati dello studio sul cancro alla prostata

Candel announces oral presentation on prostate cancer trial data

Paul Manning acquista azioni Candel Therapeutics (CADL) per 3 mln $

Le azioni Candel Therapeutics calano dopo il pricing dell’offerta da 100 milioni di dollari

Candel Therapeutics stock falls on $100 million offering pricing

Why Is Candel Therapeutics Stock Falling Friday? - Candel Therapeutics (NASDAQ:CADL)

New Strong Sell Stocks for January 20th

Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday - Candel Therapeutics (NASDAQ:CADL), Centene (NYSE:CNC)